Columbia University Fertility Center – FDA 483, Nov 28, 2022
An FDA inspection of Columbia University Fertility Center in New York revealed significant deficiencies in their handling of Human Cells, Tissues, and Cellular and Tissue-Based Products (HCT/Ps). The facility failed to properly determine donor eligibility, maintain confidential donor records, ensure communicable disease testing was performed by certified laboratories, and establish adequate screening procedures. These issues indicate a lack of compliance with regulations governing reproductive human tissue processing.
ID · a66c8dc5-3fff-414c-94cd-864dfb7e4fc9
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.